🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOrforglipron Phase 2 weight loss data — 14.7% at 36 weeks Page 4

Orforglipron Phase 2 weight loss data — 14.7% at 36 weeks

TrialNerd_Beth Thu, May 14, 2026 at 7:12 AM 17 replies 639 viewsPage 4 of 4
KarenAZ_mom
Member
567
2,567
Aug 2024
Scottsdale, AZ
May 21, 2026 at 7:15 AM#16
Dr.SleepRoch said:
It helps to say which part of this you are uncertain about.

Second this. I had assumed I was the exception until I read this.

Last edited: May 21, 2026 at 12:15 PM
9 7anna.melb_AU, mark_tokyo, hans_munich and 6 others
Reply Quote Save Share Report
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
May 21, 2026 at 2:24 PM#17
DataDave said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

Last edited: May 21, 2026 at 3:24 PM
10 8Dr.PulmRoch, maya_sedona, stefan_berlin and 7 others
Reply Quote Save Share Report
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
May 21, 2026 at 9:33 PM#18
DataDave said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

That reframing is the part I needed. Adding it to my notes with a link back to this thread.

11 9tommy_boulder, hyun_seoul, jim_asheville and 8 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
anna.melb_AU
Member
678
2,890
Apr 2024
Melbourne, AU
May 22, 2026 at 4:42 AM#19

Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

12 10tammy_FL, Dr.LipidDallas, alex_tucson and 9 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
May 22, 2026 at 11:51 AM#20

Moderator note: the sourcing question belongs in the vendor section and has been split out. Thread quality here is what the rules are for. Keep it up.

Last edited: May 22, 2026 at 3:51 PM
34 7PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 31 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register